Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.545 USD | +8.80% | +8.80% | +5.10% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 48.23M | Sales 2025 * | 47.83M | Capitalization | 83.26M |
---|---|---|---|---|---|
Net income 2024 * | -53M | Net income 2025 * | -62M | EV / Sales 2024 * | 1.73 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.74 x |
P/E ratio 2024 * |
-1.65
x | P/E ratio 2025 * |
-1.62
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.84% |
Latest transcript on Spero Therapeutics, Inc.
1 day | +8.80% | ||
1 week | +8.80% | ||
Current month | +8.80% | ||
1 month | -13.69% | ||
3 months | -1.59% | ||
6 months | +35.53% | ||
Current year | +5.10% |
Managers | Title | Age | Since |
---|---|---|---|
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 21-01-03 |
Ankit Mahadevia
FOU | Founder | 43 | 13-03-31 |
Esther Rajavelu
DFI | Director of Finance/CFO | 46 | Nov. 05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Thomas
BRD | Director/Board Member | 54 | 17-06-30 |
John Pottage
BRD | Director/Board Member | 71 | 18-08-13 |
Scott Jackson
BRD | Director/Board Member | 60 | 20-04-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 1.545 | +8.80% | 281,998 |
24-04-30 | 1.42 | -1.39% | 95,314 |
24-04-29 | 1.44 | -1.37% | 170,558 |
24-04-26 | 1.46 | +2.10% | 165,357 |
24-04-25 | 1.43 | +0.70% | 175,454 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.10% | 83.26M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.87% | 22.25B | |
-14.77% | 21.68B | |
-8.98% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- SPRO Stock